TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.80
+0.79 (5.64%)
Oct 19, 2026, 4:00 PM EDT - Market closed
TRex Bio Market Cap
TRex Bio has a market cap or net worth of $398.45 million as of October 19, 2026. It is the 16,233rd most valuable company in the world and the 2,907th biggest in the United States.
Market Cap
398.45M
Enterprise Value
307.79M
1-Year Change
n/a
Global Rank
Country Rank
#2,907 United States
Category
ChartMarket Cap Chart
Since the IPO on October 9, 2026, TRex Bio's market cap has increased from $384.24M to $398.45M, an increase of 3.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 398.45M | 5.64% |
| Oct 16, 2026 | 377.18M | -1.06% |
| Oct 15, 2026 | 381.22M | 4.89% |
| Oct 14, 2026 | 363.45M | -0.74% |
| Oct 13, 2026 | 366.14M | -3.06% |
| Oct 12, 2026 | 377.72M | -1.70% |
| Oct 9, 2026 | 384.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 403.69M |
| ProKidney | 402.09M |
| Eikon Therapeutics | 401.90M |
| ARS Pharmaceuticals | 399.78M |
| Capricor Therapeutics | 390.11M |
| Scribe Therapeutics | 380.15M |
| Rezolute | 375.53M |
| Zura Bio | 371.82M |